Scott F Huntington

31PUBLICATIONS
105CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Forensic epidemiologyEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Oct 20, 2026
Survival Outcomes in Chronic Lymphocytic Leukemia During the Novel Agent Era: A Population-Based Analysis.

|Sep 30, 2026
Insurance and Cost-Related Access Barriers to Specialty Oral Anticancer Medications for Blood Cancers in a Nationwide Sample of Medicare and Commercially Insured Patients.

|Sep 10, 2026
Peripheral CD8⁺ T-cell clonality and NK-cell expansion mark early response to mosunetuzumab in indolent B-cell lymphoma.

|Jul 28, 2025
Cost-effectiveness of upfront vs delayed allogeneic hematopoietic stem cell transplant for intermediate risk AML.

Abdulrahman Alhajahjeh, Kishan K Patel, Nikolai A Podoltsev

|Dec 20, 2024
Real-World Treatment Patterns After Discontinuation of Venetoclax or BTKis in the Frontline Setting Among Older Adults With Chronic Lymphocytic Leukemia.

Scott F Huntington, Joanna M Rhodes, Beenish S Manzoor

|Aug 08, 2024
Costs of care during chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell lymphomas.

Mengyang Di, Kunal C Potnis, Jessica B Long

Pageof 6

Frequent Collaborators

8 joint publications

Nikolai A Podoltsev

6 joint publications

Amy J Davidoff

6 joint publications

Rory M Shallis

4 joint publications

Mengyang Di